Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

403 ARTÍCULOS , VIENDO DEL 166 AL 180

Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease

Schmidt C, Gerlach N, Schmitz M, Thom T, Kramer K, Friede T, Zerr I.

J Alzheimers Dis. 2015;48(1):189-96. doi: 10.3233/JAD-150286.

The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease

Pistollato F, Cano SS, Elio I, Vergara MM, Giampieri F, Battino M.

J Alzheimers Dis. 2015;48(2):303-18. doi: 10.3233/JAD-150301.

Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial

Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F.

J Alzheimers Dis. 2015;48(2):377-83. doi: 10.3233/JAD-141983.

Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study

Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.

J Alzheimers Dis. 2015;48(2):473-81. doi: 10.3233/JAD-150414.

Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease

Samuraki M, Matsunari I, Yoshita M, Shima K, Noguchi-Shinohara M, Hamaguchi T, Ono K, Yamada M.

J Alzheimers Dis. 2015;48(2):517-28. doi: 10.3233/JAD-150274.

Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial

Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S; GuidAge study group.

J Alzheimers Dis. 2015;48(3):793-804. doi: 10.3233/JAD-150013.

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J.

J Alzheimers Dis. 2015;48(3):805-12. doi: 10.3233/JAD-150102.

Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials

Menéndez-González M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrión O.

J Alzheimers Dis. 2015;48(3):581-9. doi: 10.3233/JAD-150226.

Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)

Matsuzono K, Sato K, Kono S, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K.

J Alzheimers Dis. 2015;48(3):757-63. doi: 10.3233/JAD-150518.

New Perspectives on Alzheimer's Disease and Nutrition

Gustafson DR, Clare Morris M, Scarmeas N, Shah RC, Sijben J, Yaffe K, Zhu X.

J Alzheimers Dis. 2015;46(4):1111-27. doi: 10.3233/JAD-150084.

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease

Liu-Seifert H, Siemers E, Price K, Han B, Selzler KJ, Henley D, Sundell K, Aisen P, Cummings J, Raskin J, Mohs R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(1):205-14. doi: 10.3233/JAD-142508.

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Bukhari SN, Jantan I.

Mini Rev Med Chem. 2015;15(13):1110-21. doi: 10.2174/138955751513150923101841.

Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands

Khalsa DS.

J Alzheimers Dis. 2015;48(1):1-12. doi: 10.3233/JAD-142766.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias